Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lipo Lab PPC Solution is a lipolytic injectable product designed for non-surgical body contouring and localized fat reduction. It contains a combination of phosphatidylcholine (PPC) and sodium deoxycholate (DC) as its primary active ingredients. The mechanism of action involves the detergent-like disruption of adipocyte (fat cell) membranes by sodium deoxycholate, leading to cell lysis. Phosphatidylcholine then aids in the emulsification and transport of the released lipids for metabolic clearance. The product was distributed by Vivid-Scientific LLC and marketed for the treatment of fat deposits in areas such as the double chin, abdomen, thighs, and arms. In March 2025, the FDA issued a warning letter to the distributor, noting that the product was being sold as an unapproved new drug in violation of federal law.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Lipo Lab PPC Solution.